Goldshleger Ilya 4
4 · RxSight, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Goldshleger Ilya
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2024-11-18$15.08/sh+3,100$46,748→ 45,346 total - Sale
Common Stock
2024-11-18$45.00/sh−3,067$138,015→ 42,279 total - Sale
Common Stock
2024-11-18$45.07/sh−33$1,487→ 42,246 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-15−4,875→ 53,182 totalExercise: $15.08Exp: 2030-04-22→ Common Stock (4,875 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-11-18−3,100→ 50,082 totalExercise: $15.08Exp: 2030-04-22→ Common Stock (3,100 underlying) - Sale
Common Stock
2024-11-15$46.00/sh−4,875$224,250→ 42,246 total - Exercise/Conversion
Common Stock
2024-11-15$15.08/sh+4,875$73,515→ 47,121 total
Holdings
- 1,372(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person.
- [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020.